In a continually competitive and challenging market, patient-centric clinical trials are becoming increasingly important to biopharmaceutical companies who are keen to bring their drugs to market ...
The vast majority of drugmakers are either considering or have already established direct-to-patient (DTP) programs, cutting out middlemen to offer services like virtual care consultations, payment ...
A recent survey shows that healthcare professionals have varied feelings on the direct-to-patient (DTP) drug sale platforms increasingly being launched by pharma companies—echoing patients’ own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback